XML 24 R10.htm IDEA: XBRL DOCUMENT v3.25.0.1
CASH AND CASH EQUIVALENTS AND MARKETABLE SECURITIES
12 Months Ended
Dec. 31, 2023
Cash and Cash Equivalents [Abstract]  
CASH AND CASH EQUIVALENTS AND MARKETABLE SECURITIES

NOTE 3 – CASH AND CASH EQUIVALENTS AND MARKETABLE SECURITIES

 

The following table sets forth our cash, cash equivalents and marketable securities as of December 31, 2023 and 2022:

 SCHEDULE OF CASH AND CASH EQUIVALENTS AND MARKETABLE SECURITIES

         
   As of December 31, 
   2023   2022 
Cash and cash equivalents:          
Cash  $2,468   $1,195 
U.S. treasury securities   -    1,247 
Total cash and cash equivalents  $2,468   $2,442 
           
Marketable securities:          
Money market mutual funds  $1,420   $1,999 
U.S. treasury securities   2,497    3,761 
Total marketable securities  $3,917   $5,760 
           
Total cash, cash equivalents and marketable securities  $6,385   $8,202 

 

The unrealized gains on our marketable securities were $59 and $12 for the years ended December 31, 2023 and 2022, respectively.

 

Treasuries have contractual maturities of less than 12 months.

 

 

MICROBOT MEDICAL INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands

(Except share and per share data)